Major update:
Dr. Aljammal, in this study, is investigating potential factors that may influence volume reduction (VR) following radiofrequency ablation (RFA) in patients with benign thyroid nodules.
This is a multicenter, retrospective study of 275 benign thyroid nodules in 240 patients who underwent treatment with radiofrequency ablation (RFA) between November 2018 and March 2022.